BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29084984)

  • 1. First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma.
    Kuo SH; Yeh KH; Wu MS; Lin CW; Wei MF; Liou JM; Wang HP; Chen LT; Cheng AL
    Sci Rep; 2017 Oct; 7(1):14333. PubMed ID: 29084984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
    Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
    J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21).
    Yeh KH; Kuo SH; Chen LT; Mao TL; Doong SL; Wu MS; Hsu HC; Tzeng YS; Chen CL; Lin JT; Cheng AL
    Blood; 2005 Aug; 106(3):1037-41. PubMed ID: 15845895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ; Kim N; Paik JH; Kim JM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas.
    Raderer M; Streubel B; Wöhrer S; Häfner M; Chott A
    Gut; 2006 May; 55(5):616-8. PubMed ID: 16299027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B; Ye H; Du MQ; Isaacson PG; Chott A; Raderer M
    Oncology; 2004; 66(6):476-80. PubMed ID: 15452377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma.
    Kuo SH; Yeh PY; Chen LT; Wu MS; Lin CW; Yeh KH; Tzeng YS; Chen JY; Hsu PN; Lin JT; Cheng AL
    Blood; 2008 Oct; 112(7):2927-34. PubMed ID: 18628489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment.
    Nakamura S; Matsumoto T; Ye H; Nakamura S; Suekane H; Matsumoto H; Yao T; Tsuneyoshi M; Du MQ; Iida M
    Cancer; 2006 Dec; 107(12):2770-8. PubMed ID: 17099876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
    Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
    J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight.
    Santacroce L; Cagiano R; Del Prete R; Bottalico L; Sabatini R; Carlaio RG; Prejbeanu R; Vermesan H; Dragulescu SI; Vermesan D; Motoc A; Losacco T
    Clin Ter; 2008; 159(6):457-62. PubMed ID: 19169609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy.
    Terai S; Iijima K; Kato K; Dairaku N; Suzuki T; Yoshida M; Koike T; Kitagawa Y; Imatani A; Sekine H; Ohara S; Shimosegawa T
    Tohoku J Exp Med; 2008 Jan; 214(1):79-87. PubMed ID: 18212490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
    Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.
    Nakamura T; Nakamura S; Yonezumi M; Suzuki T; Matsuura A; Yatabe Y; Yokoi T; Ohashi K; Seto M
    Jpn J Cancer Res; 2000 Mar; 91(3):301-9. PubMed ID: 10760689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
    Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
    Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma.
    Sumida T; Kitadai Y; Hiyama T; Shinagawa K; Tanaka M; Kodama M; Masuda H; Ito M; Tanaka S; Yoshihara M; Chayama K
    Cancer Sci; 2009 Jun; 100(6):1075-81. PubMed ID: 19385974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
    Kuo SH; Cheng AL; Lin CW; Hsu CH; Wu MS; Yeh KH; Tzeng YS; Chen LT
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1387-95. PubMed ID: 21465313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.